|
1.
|
Ong JP, Pitts A and Younossi ZM: Increased
overall mortality and liver-related mortality in non-alcoholic
fatty liver disease. J Hepatol. 49:608–612. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Dowman JK, Tomlinson JW and Newsome PN:
Pathogenesis of non-alcoholic fatty liver disease. QJM. 103:71–83.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Shifflet A and Wu GY: Non-alcoholic
steatohepatitis: an overview. J Formos Med Assoc. 108:4–12. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Argo CK and Caldwell SH: Epidemiology and
natural history of non-alcoholic steatohepatitis. Clin Liver Dis.
13:511–531. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Bellentani S, Scaglioni F, Marino M and
Bedogni G: Epidemiology of non-alcoholic fatty liver disease. Dig
Dis. 28:155–161. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Chen CH, Huang MH, Yang JC, et al:
Prevalence and risk factors of nonalcoholic fatty liver disease in
an adult population of Taiwan: metabolic significance of
nonalcoholic fatty liver disease in nonobese adults. J Clin
Gastroenterol. 40:745–752. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Zhou YJ, Li YY, Nie YQ, et al: Prevalence
of fatty liver disease and its risk factors in the population of
South China. World J Gastroenterol. 13:6419–6424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Woo KS, Chook P, Raitakari OT, McQuillan
B, Feng JZ and Celermajer DS: Westernization of Chinese adults and
increased subclinical atherosclerosis. Arterioscler Thromb Vasc
Biol. 19:2487–2493. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Leng SX, Tian XP, Durso S, et al: The
aging population and development of geriatrics in China. J Am
Geriatr Soc. 56:571–573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Adams LA, Lymp JF, St Sauver J, et al: The
natural history of nonalcoholic fatty liver disease: a
population-based cohort study. Gastroenterology. 129:113–121. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Hashimoto E, Yatsuji S, Tobari M, et al:
Hepatocellular carcinoma in patients with nonalcoholic
steatohepatitis. J Gastroenterol. 44(Suppl 19): S89–S95. 2009.
View Article : Google Scholar
|
|
12.
|
Tarantino G: Should nonalcoholic fatty
liver disease be regarded as a hepatic illness only? World J
Gastroenterol. 13:4669–4672. 2007.PubMed/NCBI
|
|
13.
|
Hamaguchi M, Kojima T, Takeda N, et al:
The metabolic syndrome as a predictor of nonalcoholic fatty liver
disease. Ann Intern Med. 143:722–728. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kim HM, Kim DJ, Jung IH, Park C and Park
J: Prevalence of the metabolic syndrome among Korean adults using
the new International Diabetes Federation definition and the new
abdominal obesity criteria for the Korean people. Diabetes Res Clin
Pract. 77:99–106. 2007. View Article : Google Scholar
|
|
15.
|
Seo HI, Cho YK, Lee WY, et al: Which
metabolic syndrome criteria best predict the presence of
non-alcoholic fatty liver disease? Diabetes Res Clin Pract.
95:19–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Kotronen A and Yki-Järvinen H: Fatty
liver: a novel component of the metabolic syndrome. Arterioscler
Thromb Vasc Biol. 28:27–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Chang TY and Chen JD: Fatty liver and
metabolic syndrome in nonabdominally obese Taiwanese adults. Asia
Pac J Public Health. 24:472–479. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Chen SH, He F, Zhou HL, Wu HR, Xia C and
Li YM: Relationship between nonalcoholic fatty liver disease and
metabolic syndrome. J Dig Dis. 12:125–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Fan JG, Zhu J, Li XJ, et al: Fatty liver
and the metabolic syndrome among Shanghai adults. J Gastroenterol
Hepatol. 20:1825–1832. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Graham RC, Burke A and Stettler N: Ethnic
and sex differences in the association between metabolic syndrome
and suspected nonalcoholic fatty liver disease in a nationally
representative sample of US adolescents. J Pediatr Gastroenterol
Nutr. 49:442–449. 2009. View Article : Google Scholar
|
|
21.
|
Onyekwere CA, Ogbera AO and Balogun BO:
Non-alcoholic fatty liver disease and the metabolic syndrome in an
urban hospital serving an African community. Ann Hepatol.
10:119–124. 2011.PubMed/NCBI
|
|
22.
|
Tsai CH, Li TC and Lin CC: Metabolic
syndrome as a risk factor for nonalcoholic fatty liver disease.
South Med J. 101:900–905. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Zhou YJ, Li YY, Nie YQ, Huang CM and Cao
CY: Natural course of nonalcoholic fatty liver disease in southern
China: a prospective cohort study. J Dig Dis. 13:153–160. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Xu L, Jiang CQ, Lam TH, et al: The
metabolic syndrome is associated with subclinical atherosclerosis
independent of insulin resistance: the Guangzhou Biobank Cohort
Study-CVD. Clin Endocrinol (Oxf). 73:181–188. 2010.PubMed/NCBI
|
|
25.
|
Bedogni G, Miglioli L, Masutti F,
Tiribelli C, Marchesini G and Bellentani S: Prevalence of and risk
factors for nonalcoholic fatty liver disease: the Dionysos
nutrition and liver study. Hepatology. 42:44–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Hernaez R, Lazo M, Bonekamp S, et al:
Diagnostic accuracy and reliability of ultrasonography for the
detection of fatty liver: a meta-analysis. Hepatology.
54:1082–1090. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Alberti KG, Eckel RH, Grundy SM, et al:
Harmonizing the metabolic syndrome: a joint interim statement of
the International Diabetes Federation Task Force on Epidemiology
and Prevention; National Heart, Lung, and Blood Institute; American
Heart Association; World Heart Federation; International
Atherosclerosis Society; and International Association for the
Study of Obesity. Circulation. 120:1640–1645. 2009.
|
|
28.
|
Hamaguchi M, Kojima T, Itoh Y, et al: The
severity of ultra-sonographic findings in nonalcoholic fatty liver
disease reflects the metabolic syndrome and visceral fat
accumulation. Am J Gastroenterol. 102:2708–2715. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Lin YC, Chou SC, Huang PT and Chiou HY:
Risk factors and predictors of non-alcoholic fatty liver disease in
Taiwan. Ann Hepatol. 10:125–132. 2011.PubMed/NCBI
|
|
30.
|
Seppälä-Lindroos A, Vehkavaara S, Häkkinen
AM, et al: Fat accumulation in the liver is associated with defects
in insulin suppression of glucose production and serum free fatty
acids independent of obesity in normal men. J Clin Endocrinol
Metab. 87:3023–3028. 2002.PubMed/NCBI
|
|
31.
|
Kotronen A, Westerbacka J, Bergholm R,
Pietiläinen KH and Yki-Järvinen H: Liver fat in the metabolic
syndrome. J Clin Endocrinol Metab. 92:3490–3497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Medina J, Fernández-Salazar LI,
Garcia-Buey L and Moreno-Otero R: Approach to the pathogenesis and
treatment of nonalcoholic steatohepatitis. Diabetes Care.
27:2057–2066. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Jain KA and McGahan JP: Spectrum of CT and
sonographic appearance of fatty infiltration of the liver. Clin
Imaging. 17:162–168. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Fishbein M, Castro F, Cheruku S, et al:
Hepatic MRI for fat quantitation: its relationship to fat
morphology, diagnosis, and ultrasound. J Clin Gastroenterol.
39:619–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Danet IM, Semelka RC and Braga L: MR
imaging of diffuse liver disease. Radiol Clin North Am. 41:67–87.
2003. View Article : Google Scholar : PubMed/NCBI
|
